Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.03 USD | +0.62% | +17.42% | +1.68% |
Chart calendar Cartesian Therapeutics, Inc.
Upcoming events on Cartesian Therapeutics, Inc.
Past events on Cartesian Therapeutics, Inc.
10/04/2024 12:30 am | Needham Healthcare Conference |
27/03/2024 06:30 pm | Extraordinary Shareholders Meeting |
26/03/2024 08:30 pm | H.C. Wainwright Cell Therapy Virtual Conference |
13/03/2024 06:10 pm | Leerink Partners Global Biopharma Conference |
07/03/2024 05:30 pm | Q4 2023 Earnings Release |
17/08/2023 06:00 pm | Q2 2023 Earnings Call |
17/08/2023 04:30 pm | Q2 2023 Earnings Release |
16/06/2023 07:30 pm | Annual General Meeting |
31/05/2023 | European Alliance of Associations for Rheumatology European Congress |
04/05/2023 06:00 pm | Q1 2023 Earnings Call |
04/05/2023 05:00 pm | Q1 2023 Earnings Release |
21/03/2023 06:00 pm | DISSOLVE I & II SEL-212 Phase 3 Trail Results Call |
02/03/2023 07:00 pm | Q4 2022 Earnings Call |
02/03/2023 | Q4 2022 Earnings Release |
14/02/2023 06:30 pm | SVB Securities Global Biopharma Conference |
15/11/2022 12:05 am | Immunology & Neurology Day |
03/11/2022 06:00 pm | Q3 2022 Earnings Call |
03/11/2022 05:30 pm | Q3 2022 Earnings Release |
11/10/2022 10:00 pm | European Society of Gene and Cell Therapy Conference - OR06 |
01/10/2022 12:00 am | Jefferies Cell and Genetic Medicine Summit |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 26,0 10,6 145.32% | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -86,4 -14,3 -506.39% | -40,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,46 | -239 -13,7 -1645.21% | -32,2 |
Net income Million USD | Released Forecast Spread | -6,46 | -220 -13,7 -1506.3% | -37,8 |
EPS USD | Released Forecast Spread | 0,00 | -49,8 -0,60 -8200.01% | -1,62 |
Announcement Date | 23/01/24 | 07/03/24 | - |
Quarterly results
Fiscal Period | December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2,50 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -6,00 | -8,63 | -9,00 | -10,4 | -12,3 | -14,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,91 | -6,29 | -7,62 | -8,46 | -9,81 | -10,9 |
Net income Million USD | Released Forecast Spread | -5,91 | -8,14 | -8,31 | -9,73 | -11,7 | -13,5 |
EPS USD | Released Forecast Spread | -0,30 | -0,35 | -0,36 | -0,42 | -0,50 | -0,57 |
Announcement Date | - | - | - | - | - | - |
Past sector events for Cartesian Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RNAC Stock
- Calendar Cartesian Therapeutics, Inc.